EFO-27

Cat.No.: CSC-C0318

Species: Human

Source: ovary adenocarcinoma

Morphology: adherent, epithelial-like cells growing as monolayers

Culture Properties: monolayer

Inquire for Price

Specification
Q & A
Customer Review

Cat.No.

CSC-C0318

Description

Established from the solid omental metastasis of a mucinous papillary adenocarcinoma of the ovary of a 36-year-old woman in 1979; initially diploid, later tetraploid; growth in nude mice

Species

Human

Source

ovary adenocarcinoma

Recommended Medium

80% RPMI-1640 + 2 mM L-glutamine + 1 mM sodium pyruvate + 20% h.i. FBS + 1x non-essential amino acids

Culture Properties

monolayer

Morphology

adherent, epithelial-like cells growing as monolayers

Karyotype

Human flat-moded hypotetraploid karyotype with 17% polyploidy - 78-91<4n>XXXX, -4, -10, -13, -13, -19, +mar - i(9q), 16qh+x2 - extensive subclonal rearrangements, e.g. der(5)t(5;7)(q31.2;q11)

Quality Control

Mycoplasma: negative in DAPI, microbiological culture, RNA hybridization, PCR assays
Immunology: cytokeratin +, cytokeratin-7 +, cytokeratin-8 +, cytokeratin-17 -, cytokeratin-18 +, cytokeratin-19 +, desmin -, endothel -, EpCAM +, GFAP -, neurofilament -,

Storage and Shipping

Frozen with 70% medium, 20% FBS, 10% DMSO at about 2 x 10^6 cells/ampoule; ship in dry ice; store in liquid nitrogen

Citation Guidance

If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.

What information can be obtained from animal models of ovarian cancer?

Animal models of ovarian cancer allow researchers to study tumor growth, metastasis, and the interaction between the tumor and the immune system. These models can also be used to test potential therapies before advancing to human clinical trials.

Ask a Question

Average Rating: 5.0 | 1 Scientist has reviewed this product

Strict aseptic techniques

Creative Bioarray employs strict aseptic techniques in the preparation and handling of tumor cell products to minimize the risk of contamination and ensure high purity and reliable results.

08 Nov 2022

Ease of use
After sales services
Value for money

Write your own review

You May Also Need

CM-1103X

SuperCult® RPMI-1640 Cell Culture Medium +HEPES, +Sodium Pyruvate

INQUIRY

CM-1268W

SuperCult® Non-Essential Amino Acid (NEAA) Cell Culture Supplement

INQUIRY

CS-001Y

PremSera® FBS

INQUIRY

OC 316

Description: Species: human female 60 years old;
Tissue: ovary;
Tumor: adenocarcinoma, low differentiated;
G3 FIGO stage IV (pleural metastasis);
Derived from: ascitic fluid

Cat#: CSC-6307W INQUIRY

View Product

COLO-704

Description: Established from the ascites fluid stemming from the colon metastasis of a 46-year-old white woman with ovarian adenocarcinoma in 1986

Cat#: CSC-C0323 INQUIRY

View Product

EFO-21

Description: Established from the ascitic fluid of a 56-year-old Caucasian woman with dedifferentiated serous cystadenocarcinoma of the ovary in 1979

Cat#: CSC-C0341 INQUIRY

View Product

FU-OV-1

Description: Established post-hysterectomy from the tumor tissue of a 65-year-old Japanese woman with malignant ovarian carcinoma (stage: FIGO IIIc; histology: poorly differentiated serous papillary adenocarcinoma) in 1989

Cat#: CSC-C0477 INQUIRY

View Product

Caov-3

Description: The cells are distributed for research purposes only. The culture condition is 37℃，95% air, carbon dioxide (CO2), complete growth medium supplemented with 5% (v/v) DMSO

Cat#: CSC-C9094W INQUIRY

View Product

OVCAR-3

Description: Established in 1982 by T.C. Hamilton, et al. from the malignant ascites of a patient with progressive adenocarcinoma of the ovary.

Cat#: CSC-C9120W INQUIRY

View Product

For research use only. Not for any other purpose.